Nils Lindefors, M.D., Ph.D. - Publications

Affiliations: 
Psychiatry Karolinska Institute, Stockholm, Sweden 

151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 El Alaoui S, Hedman E, Ljótsson B, Lindefors N. Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive-behavioural therapy for social anxiety disorder in routine psychiatric care. Bmj Open. 5: e007902. PMID 26105031 DOI: 10.1136/bmjopen-2015-007902  1
2015 El Alaoui S, Hedman E, Kaldo V, Hesser H, Kraepelien M, Andersson E, Rück C, Andersson G, Ljótsson B, Lindefors N. Effectiveness of Internet-based cognitive-behavior therapy for social anxiety disorder in clinical psychiatry. Journal of Consulting and Clinical Psychology. 83: 902-14. PMID 26009780 DOI: 10.1037/a0039198  1
2015 Blom K, Tarkian Tillgren H, Wiklund T, Danlycke E, Forssén M, Söderström A, Johansson R, Hesser H, Jernelöv S, Lindefors N, Andersson G, Kaldo V. Internet-vs. group-delivered cognitive behavior therapy for insomnia: A randomized controlled non-inferiority trial. Behaviour Research and Therapy. 70: 47-55. PMID 25981329 DOI: 10.1016/j.brat.2015.05.002  1
2015 Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. Jama Psychiatry. 72: 659-67. PMID 25970252 DOI: 10.1001/jamapsychiatry.2015.0546  1
2015 El Alaoui S, Ljótsson B, Hedman E, Kaldo V, Andersson E, Rück C, Andersson G, Lindefors N. Predictors of Symptomatic Change and Adherence in Internet-Based Cognitive Behaviour Therapy for Social Anxiety Disorder in Routine Psychiatric Care. Plos One. 10: e0124258. PMID 25893687 DOI: 10.1371/journal.pone.0124258  1
2015 Hedman E, Lekander M, Ljótsson B, Lindefors N, Rück C, Andersson G, Andersson E. Optimal cut-off points on the health anxiety inventory, illness attitude scales and whiteley index to identify severe health anxiety. Plos One. 10: e0123412. PMID 25849477 DOI: 10.1371/journal.pone.0123412  1
2015 Hedman E, Ljótsson B, Andersson E, Andersson G, Lindefors N, Rück C, Axelsson E, Lekander M. Psychometric properties of Internet-administered measures of health anxiety: an investigation of the Health Anxiety Inventory, the Illness Attitude Scales, and the Whiteley Index. Journal of Anxiety Disorders. 31: 32-7. PMID 25723780 DOI: 10.1016/j.janxdis.2015.01.008  1
2015 Blom K, Jernelöv S, Kraepelien M, Bergdahl MO, Jungmarker K, Ankartjärn L, Lindefors N, Kaldo V. Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial. Sleep. 38: 267-77. PMID 25337948 DOI: 10.5665/sleep.4412  1
2015 Andersson E, Hedman E, Ljótsson B, Wikström M, Elveling E, Lindefors N, Andersson G, Kaldo V, Rück C. Cost-effectiveness of internet-based cognitive behavior therapy for obsessive-compulsive disorder: Results from a randomized controlled trial Journal of Obsessive-Compulsive and Related Disorders. 4: 47-53. DOI: 10.1016/j.jocrd.2014.12.004  1
2015 Andersson E, Ljótsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Predictors and moderators of Internet-based cognitive behavior therapy for obsessive-compulsive disorder: Results from a randomized trial Journal of Obsessive-Compulsive and Related Disorders. 4: 1-7. DOI: 10.1016/j.jocrd.2014.10.003  1
2015 Andersson E, Ljótsson B, Hedman E, Mattson S, Enander J, Andersson G, Kaldo V, Lindefors N, Rück C. Cost-effectiveness of an internet-based booster program for patients with obsessive-compulsive disorder: Results from a randomized controlled trial Journal of Obsessive-Compulsive and Related Disorders. 4: 14-19. DOI: 10.1016/j.jocrd.2014.10.002  1
2015 Kraepelien M, Svenningsson P, Lindefors N, Kaldo V. Internet-based cognitive behavioral therapy for depression and anxiety in parkinson's disease - a pilot study Internet Interventions. 2: 1-6. DOI: 10.1016/j.invent.2014.11.006  1
2015 Moëll B, Kollberg L, Nasri B, Lindefors N, Kaldo V. Living smart - a randomized controlled trial of a guided online course teaching adults with adhd or sub-clinical adhd to use smartphones to structure their everyday life Internet Interventions. 2: 24-31. DOI: 10.1016/j.invent.2014.11.004  1
2015 Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, Kraepelien M, Rück C, Lindefors N. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment - A randomized trial Behaviour Research and Therapy. 71: 90-100. DOI: 10.1016/j.brat.2015.06.001  1
2014 Hedman E, Andersson G, Lindefors N, Gustavsson P, Lekander M, Rück C, Andersson E, Ljótsson B. Personality change following internet-based cognitive behavior therapy for severe health anxiety. Plos One. 9: e113871. PMID 25437150 DOI: 10.1371/journal.pone.0113871  1
2014 Andersson E, Ljótsson B, Hedman E, Hesser H, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Testing the Mediating Effects of Obsessive Beliefs in Internet-Based Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder: Results from a Randomized Controlled Trial. Clinical Psychology & Psychotherapy. PMID 25418575 DOI: 10.1002/cpp.1931  1
2014 Gajecki M, Berman AH, Sinadinovic K, Andersson C, Ljótsson B, Hedman E, Rück C, Lindefors N. Effects of baseline problematic alcohol and drug use on internet-based cognitive behavioral therapy outcomes for depression, panic disorder and social anxiety disorder. Plos One. 9: e104615. PMID 25122509 DOI: 10.1371/journal.pone.0104615  1
2014 Andersson E, Steneby S, Karlsson K, Ljótsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Rück C. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychological Medicine. 44: 2877-87. PMID 25066102 DOI: 10.1017/S0033291714000543  1
2014 Schibbye P, Ghaderi A, Ljótsson B, Hedman E, Lindefors N, Rück C, Kaldo V. Using early change to predict outcome in cognitive behaviour therapy: exploring timeframe, calculation method, and differences of disorder-specific versus general measures. Plos One. 9: e100614. PMID 24959666 DOI: 10.1371/journal.pone.0100614  1
2014 Hedman E, El Alaoui S, Lindefors N, Andersson E, Rück C, Ghaderi A, Kaldo V, Lekander M, Andersson G, Ljótsson B. Clinical effectiveness and cost-effectiveness of Internet- vs. group-based cognitive behavior therapy for social anxiety disorder: 4-year follow-up of a randomized trial. Behaviour Research and Therapy. 59: 20-9. PMID 24949908 DOI: 10.1016/j.brat.2014.05.010  1
2014 Tiger M, Rück C, Forsberg A, Varrone A, Lindefors N, Halldin C, Farde L, Lundberg J. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research. 223: 164-70. PMID 24916155 DOI: 10.1016/j.pscychresns.2014.05.011  1
2014 Hedman E, Lekander M, Ljótsson B, Lindefors N, Rück C, Hofmann SG, Andersson E, Andersson G, Schulz SM. Sudden gains in internet-based cognitive behaviour therapy for severe health anxiety. Behaviour Research and Therapy. 54: 22-9. PMID 24468920 DOI: 10.1016/j.brat.2013.12.007  1
2014 Hedman E, Ljótsson B, Kaldo V, Hesser H, El Alaoui S, Kraepelien M, Andersson E, Rück C, Svanborg C, Andersson G, Lindefors N. Effectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric care. Journal of Affective Disorders. 155: 49-58. PMID 24238951 DOI: 10.1016/j.jad.2013.10.023  1
2013 Andersson E, Rück C, Lavebratt C, Hedman E, Schalling M, Lindefors N, Eriksson E, Carlbring P, Andersson G, Furmark T. Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. Plos One. 8: e79015. PMID 24260145 DOI: 10.1371/journal.pone.0079015  1
2013 Vigerland S, Thulin U, Ljótsson B, Svirsky L, Ost LG, Lindefors N, Andersson G, Serlachius E. Internet-delivered CBT for children with specific phobia: a pilot study. Cognitive Behaviour Therapy. 42: 303-14. PMID 24245708 DOI: 10.1080/16506073.2013.844201  1
2013 El Alaoui S, Hedman E, Ljótsson B, Bergström J, Andersson E, Rück C, Andersson G, Lindefors N. Predictors and moderators of internet- and group-based cognitive behaviour therapy for panic disorder. Plos One. 8: e79024. PMID 24244406 DOI: 10.1371/journal.pone.0079024  1
2013 Hedman E, Andersson E, Andersson G, Lindefors N, Lekander M, Rück C, Ljótsson B. Mediators in internet-based cognitive behavior therapy for severe health anxiety. Plos One. 8: e77752. PMID 24147073 DOI: 10.1371/journal.pone.0077752  1
2013 Hedman E, Ljótsson B, Blom K, El Alaoui S, Kraepelien M, Rück C, Andersson G, Svanborg C, Lindefors N, Kaldo V. Telephone versus internet administration of self-report measures of social anxiety, depressive symptoms, and insomnia: psychometric evaluation of a method to reduce the impact of missing data. Journal of Medical Internet Research. 15: e229. PMID 24140566 DOI: 10.2196/jmir.2818  1
2013 Hedman E, Lindefors N, Andersson G, Andersson E, Lekander M, Rück C, Ljótsson B. Predictors of outcome in Internet-based cognitive behavior therapy for severe health anxiety. Behaviour Research and Therapy. 51: 711-7. PMID 23994252 DOI: 10.1016/j.brat.2013.07.009  1
2013 Ljótsson B, Hesser H, Andersson E, Lindfors P, Hursti T, Rück C, Lindefors N, Andersson G, Hedman E. Mechanisms of change in an exposure-based treatment for irritable bowel syndrome. Journal of Consulting and Clinical Psychology. 81: 1113-26. PMID 23750460 DOI: 10.1037/a0033439  1
2013 Vigerland S, Thulin U, Ljótsson B, Svirsky L, Bengtsson O, Lindefors N, Andersson G, Serlachius E. [Computerized therapy for anxiety disorders should also be considered for children and adolescents. Can give better access to evidence-based treatment]. LäKartidningen. 110: 92-4. PMID 23424987  1
2013 Hedman E, Ljótsson B, Rück C, Bergström J, Andersson G, Kaldo V, Jansson L, Andersson E, Andersson E, Blom K, El Alaoui S, Falk L, Ivarsson J, Nasri B, Rydh S, ... Lindefors N, et al. Effectiveness of internet-based cognitive behaviour therapy for panic disorder in routine psychiatric care. Acta Psychiatrica Scandinavica. 128: 457-67. PMID 23406572 DOI: 10.1111/acps.12079  1
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/j.euroneuro.2012.04.019  1
2013 Hedman E, Andersson E, Lindefors N, Andersson G, Rück C, Ljótsson B. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychological Medicine. 43: 363-74. PMID 22608115 DOI: 10.1017/S0033291712001079  1
2012 Hedman E, Ljótsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 745-64. PMID 23252357 DOI: 10.1586/erp.12.67  1
2012 Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational Psychiatry. 2: e120. PMID 22832965 DOI: 10.1038/tp.2012.40  1
2012 Ginsberg Y, Hirvikoski T, Grann M, Lindefors N. Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. European Archives of Psychiatry and Clinical Neuroscience. 262: 705-24. PMID 22526730 DOI: 10.1007/s00406-012-0317-8  1
2012 Andersson E, Enander J, Andrén P, Hedman E, Ljótsson B, Hursti T, Bergström J, Kaldo V, Lindefors N, Andersson G, Rück C. Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychological Medicine. 42: 2193-203. PMID 22348650 DOI: 10.1017/S0033291712000244  1
2012 Hedman E, Andersson E, Ljótsson B, Andersson G, Andersson E, Schalling M, Lindefors N, Rück C. Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica. 126: 126-36. PMID 22320999 DOI: 10.1111/j.1600-0447.2012.01834.x  1
2012 Ginsberg Y, Lindefors N. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. The British Journal of Psychiatry : the Journal of Mental Science. 200: 68-73. PMID 22075648 DOI: 10.1192/bjp.bp.111.092940  1
2012 Enander J, Andersson E, Kaldo V, Lindefors N, Andersson G, Rück C. Internet administration of the Dimensional Obsessive-Compulsive Scale: A psychometric evaluation Journal of Obsessive-Compulsive and Related Disorders. 1: 325-330. DOI: 10.1016/j.jocrd.2012.07.008  1
2011 Ljótsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andréewitch S, Rück C, Lindefors N. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. Bmc Gastroenterology. 11: 110. PMID 21992655 DOI: 10.1186/1471-230X-11-110  1
2011 Hedman E, Andersson E, Ljótsson B, Andersson G, Rück C, Lindefors N. Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial. Behaviour Research and Therapy. 49: 729-36. PMID 21851929 DOI: 10.1016/j.brat.2011.07.009  1
2011 Andersson E, Ljótsson B, Hedman E, Kaldo V, Paxling B, Andersson G, Lindefors N, Rück C. Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study. Bmc Psychiatry. 11: 125. PMID 21812991 DOI: 10.1186/1471-244X-11-125  1
2011 Hedman E, Furmark T, Carlbring P, Ljótsson B, Rück C, Lindefors N, Andersson G. A 5-Year follow-up of internet-based cognitive behavior therapy for social anxiety disorder. Journal of Medical Internet Research. 13: e39. PMID 21676694 DOI: 10.2196/jmir.1776  1
2011 Rück C, Lindefors N, Allgulander C, Andersson G. [New research tracks pave the way for better therapy]. LäKartidningen. 108: 806-8. PMID 21638922  1
2011 Rück C, Andersson EM, Andréewitch S, Bejerot S, Ivarsson T, Bates S, Lindefors N. [Again and again--the obsessive circle can be broken]. LäKartidningen. 108: 798-801. PMID 21638920  1
2011 Andersson G, Carlbring P, Svanborg C, Bergström J, Ost LG, Lindefors N. [Panic syndrome--evil circle of incorrectly interpreted bodily signals]. LäKartidningen. 108: 795-7. PMID 21638919  1
2011 Von Knorring L, Andersson G, Lichtenstein P, Rück C, Lindefors N. [Common early-onset diseases]. LäKartidningen. 108: 787-91. PMID 21638917  1
2011 Lindefors N, Andersson G. [Anxiety is our heritage and we should administer it well]. LäKartidningen. 108: 785. PMID 21638915  1
2011 Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. The American Journal of Gastroenterology. 106: 1481-91. PMID 21537360 DOI: 10.1038/ajg.2011.139  1
2011 Hedman E, Andersson G, Ljótsson B, Andersson E, Rück C, Mörtberg E, Lindefors N. Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. Plos One. 6: e18001. PMID 21483704 DOI: 10.1371/journal.pone.0018001  1
2011 Andersson E, Ljótsson B, Smit F, Paxling B, Hedman E, Lindefors N, Andersson G, Rück C. Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial. Bmc Public Health. 11: 215. PMID 21473754 DOI: 10.1186/1471-2458-11-215  1
2011 Hedman E, Andersson G, Andersson E, Ljótsson B, Rück C, Asmundson GJ, Lindefors N. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 198: 230-6. PMID 21357882 DOI: 10.1192/bjp.bp.110.086843  1
2011 Ljótsson B, Hedman E, Lindfors P, Hursti T, Lindefors N, Andersson G, Rück C. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behaviour Research and Therapy. 49: 58-61. PMID 21092934 DOI: 10.1016/j.brat.2010.10.006  1
2011 Rück C, Ljótsson B, Lindefors N, Melin B. Nu kan du få en ganska overksam behandling som bonus till Cipralex Lakartidningen. 108.  1
2011 Andersson G, Lindefors N. Är inte ert inlägg ett exempel på det ni säger er vara emot? Lakartidningen. 108: 996-997.  1
2011 Lindefors N, Andersson G. Ångest är vår arvedel som vi bör förvalta väl Lakartidningen. 108: 785.  1
2010 Ginsberg Y, Hirvikoski T, Lindefors N. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. Bmc Psychiatry. 10: 112. PMID 21176203 DOI: 10.1186/1471-244X-10-112  1
2010 Lonsdorf TB, Rück C, Bergström J, Andersson G, Ohman A, Lindefors N, Schalling M. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. Bmc Psychiatry. 10: 99. PMID 21110842 DOI: 10.1186/1471-244X-10-99  1
2010 Hedman E, Ljótsson B, Andersson E, Rück C, Andersson G, Lindefors N. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial. Cognitive Behaviour Therapy. 39: 239-50. PMID 20972912 DOI: 10.1080/16506073.2010.496460  1
2010 Bergström J, Andersson G, Ljótsson B, Rück C, Andréewitch S, Karlsson A, Carlbring P, Andersson E, Lindefors N. Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial. Bmc Psychiatry. 10: 54. PMID 20598127 DOI: 10.1186/1471-244X-10-54  1
2010 Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N, Andersson G. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behaviour Research and Therapy. 48: 531-9. PMID 20362976 DOI: 10.1016/j.brat.2010.03.003  1
2010 Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome--an open pilot study. Journal of Behavior Therapy and Experimental Psychiatry. 41: 185-90. PMID 20079485 DOI: 10.1016/j.jbtep.2010.01.001  1
2010 Hedman E, Ljótsson B, Rück C, Furmark T, Carlbring P, Lindefors N, Andersson G. Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation Computers in Human Behavior. 26: 736-740. DOI: 10.1016/j.chb.2010.01.010  1
2009 Msghina M, Lindefors N. [Antipsychotic agents are best chosen by their adverse effect profile]. LäKartidningen. 106: 2841-2, 2844-6. PMID 19967963  1
2009 Lonsdorf TB, Rück C, Bergström J, Andersson G, Ohman A, Schalling M, Lindefors N. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1479-83. PMID 19683026 DOI: 10.1016/j.pnpbp.2009.08.004  1
2009 Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Lindefors N, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/appi.ajp.2008.08060806  1
2009 Bergström J, Andersson G, Lindefors N. Vetenskapligt stöd för vägledd KBT-baserad självhjälp vid depression via internet kan fler få behandling Lakartidningen. 106: 282-286. PMID 19271457  1
2009 Bergström J, Andersson G, Karlsson A, Andréewitch S, Rück C, Carlbring P, Lindefors N. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting. Nordic Journal of Psychiatry. 63: 44-50. PMID 18985514 DOI: 10.1080/08039480802191132  1
2009 Lindefors N. Långtidsbehandling med antipsykotika halverar mortaliteten vid schizofreni Lakartidningen. 106: 2828.  1
2008 Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, ... ... Lindefors N, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9  1
2008 Gospic K, Gunnarsson T, Fransson P, Ingvar M, Lindefors N, Petrovic P. Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology. 197: 295-307. PMID 18071677 DOI: 10.1007/s00213-007-1032-4  1
2007 Ek M, Lindefors N. [Antipsychotics--clever choices]. LäKartidningen. 104: 504-8. PMID 17375681  1
2006 Radu D, Tomkinson B, Zachrisson O, Weber G, de Belleroche J, Hirsch S, Lindefors N. Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10). Brain Research. 1104: 175-82. PMID 16822484 DOI: 10.1016/j.brainres.2006.05.059  1
2005 Andersson G, Bergström J, Carlbring P, Lindefors N. The use of the Internet in the treatment of anxiety disorders. Current Opinion in Psychiatry. 18: 73-7. PMID 16639187  1
2003 Radu D, Ahlin A, Svanborg P, Lindefors N. Pentagastrin test for anxiety--psychophysiology and personality. Psychopharmacology. 166: 139-45. PMID 12529809 DOI: 10.1007/s00213-002-1316-7  1
2002 Radu D, Ahlin A, Svanborg P, Lindefors N. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology. 161: 396-403. PMID 12073167 DOI: 10.1007/s00213-002-1044-z  1
2001 Lindefors N. [New neuroleptics--better effects or better marketing?]. LäKartidningen. 98: 4469. PMID 11699254  1
2001 Radu D, Brodin E, Weber G, Lindefors N. Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine. Brain Research. 908: 197-203. PMID 11454330 DOI: 10.1016/S0006-8993(01)02648-8  1
2001 Lindefors N. Nya neuroleptika - Bättre effekter eller bättre marknadsföring? Lakartidningen. 98: 4469.  1
2000 Zachrisson O, Nomikos GG, Marcus MM, Svensson TH, Lindefors N. Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 355-63. PMID 10974607  1
1999 Zachrisson O, de Belleroche J, Wendt KR, Hirsch S, Lindefors N. Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains. Neuroreport. 10: 3265-8. PMID 10599831  1
1999 Hurd Y, Lindefors N. [Increasing abuse of psychostimulants is alarming. New findings confirm the mechanisms behind cocaine and amphetamine addiction]. LäKartidningen. 96: 1814-6, 1819-21. PMID 10319645  1
1998 Zachrisson O, Lindefors N, Brené S. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Research. Molecular Brain Research. 60: 291-5. PMID 9757066 DOI: 10.1016/S0169-328X(98)00191-0  1
1997 Falkenberg T, Lindefors N, O'Connor WT, Zachrisson O, Camilli F, Ungerstedt U. GABA release and GAD67 mRNA expression in rat hippocampus following entorhinal cortex activation. Brain Research. Molecular Brain Research. 48: 413-6. PMID 9332739 DOI: 10.1016/S0169-328X(97)00185-X  1
1997 Lindefors N, Barati S, O'Connor WT. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Research. 759: 205-12. PMID 9221938 DOI: 10.1016/S0006-8993(97)00255-2  1
1997 Marcus MM, Nomikos GG, Malmerfelt A, Zachrisson O, Lindefors N, Svensson TH. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat. Brain Research. Molecular Brain Research. 45: 275-82. PMID 9149102 DOI: 10.1016/S0169-328X(96)00263-X  1
1997 Zachrisson O, Mathé AA, Lindefors N. Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific region of the rat striatum after electroconvulsive stimuli. European Journal of Pharmacology. 319: 191-5. PMID 9042590 DOI: 10.1016/S0014-2999(96)00861-8  1
1996 Zachrisson O, Mathé AA, Lindefors N. Effects of chronic lithium and electroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain. Brain Research. Molecular Brain Research. 43: 347-50. PMID 9037553 DOI: 10.1016/S0169-328X(96)00247-1  1
1996 Falkenberg T, Lindefors N, Camilli F, Metsis M, Ungerstedt U. Glutamate release correlates with brain-derived neurotrophic factor and trkB mRNA expression in the CA1 region of rat hippocampus. Brain Research. Molecular Brain Research. 42: 317-27. PMID 9013789 DOI: 10.1016/S0169-328X(96)00134-9  1
1996 Zachrisson O, Falkenberg T, Lindefors N. Neuronal coexistence of trkB and glutamic acid decarboxylase67 mRNAs in rat hippocampus. Brain Research. Molecular Brain Research. 36: 169-73. PMID 9011754 DOI: 10.1016/0169-328X(95)00281-V  1
1996 Zachrisson O, Lindefors N. [Cholecystokinin receptors. A target for tomorrow's psychopharmaceuticals?]. LäKartidningen. 93: 1225-7. PMID 8656838  1
1995 Smith S, Lindefors N, Hurd Y, Sharp T. Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat. Psychopharmacology. 120: 333-40. PMID 8524981 DOI: 10.1007/BF02311181  1
1995 Lindefors N, Brodin E, Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 65: 661-70. PMID 7609868 DOI: 10.1016/0306-4522(94)00550-O  1
1995 Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neuroscience Letters. 194: 89-92. PMID 7478221 DOI: 10.1016/0304-3940(95)11735-F  0.72
1995 Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience. 67: 37-48. PMID 7477907 DOI: 10.1016/0306-4522(95)00037-J  1
1995 Zachrisson O, Mathé AA, Stenfors C, Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Brain Research. Molecular Brain Research. 31: 71-85. PMID 7476035 DOI: 10.1016/0169-328X(95)00033-O  1
1994 Brené S, Herrera-Marschitz M, Persson H, Lindefors N. Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. Brain Research. Molecular Brain Research. 21: 274-82. PMID 8170351 DOI: 10.1016/0169-328X(94)90258-5  1
1994 Brené S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 985-98. PMID 8120638  1
1994 Johnson AE, Liminga U, Lidén A, Lindefors N, Gunne LM, Wiesel FA. Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain. Neuroscience. 63: 1003-20. PMID 7535390 DOI: 10.1016/0306-4522(94)90568-1  1
1993 Johansson B, Ahlberg S, van der Ploeg I, Brené S, Lindefors N, Persson H, Fredholm BB. Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 407-14. PMID 8510768 DOI: 10.1007/BF00165391  1
1993 Lindefors N, Lindén A, Brené S, Sedvall G, Persson H. CCK peptides and mRNA in the human brain. Progress in Neurobiology. 40: 671-90. PMID 8484007 DOI: 10.1016/0301-0082(93)90010-P  1
1993 Falkenberg T, Metsis M, Timmusk T, Lindefors N. Entorhinal cortex regulation of multiple brain-derived neurotrophic factor promoters in the rat hippocampus. Neuroscience. 57: 891-6. PMID 8309550 DOI: 10.1016/0306-4522(93)90034-D  1
1993 Brené S, Lindefors N, Herrera-Marschitz M, Persson H. Differential regulation of preprotachykinin-A mRNA expression in striatum by excitation of hippocampal neurons. The European Journal of Neuroscience. 5: 839-45. PMID 8281296  1
1993 Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 17: 887-903. PMID 8278600 DOI: 10.1016/0278-5846(93)90018-N  1
1993 Series H, Lindefors N. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards]. LäKartidningen. 90: 2648-52. PMID 8103135  1
1993 Vezzani A, Ruiz R, Monno A, Rizzi M, Lindefors N, Samanin R, Brodin E. Extracellular somatostatin measured by microdialysis in the hippocampus of freely moving rats: evidence for neuronal release. Journal of Neurochemistry. 60: 671-7. PMID 8093481  1
1992 Boatell LL, Lindefors N, Ballarin M, Ernfors P, Mahy N, Persson H. Activation of basal forebrain cholinergic neurons differentially regulates brain-derived neurotrophic factor mRNA expression in different projection areas. Neuroscience Letters. 136: 203-8. PMID 1641192 DOI: 10.1016/0304-3940(92)90049-D  1
1992 Lindefors N, Boatell ML, Mahy N, Persson H. Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization. Neuroscience Letters. 135: 262-4. PMID 1625807 DOI: 10.1016/0304-3940(92)90451-C  1
1992 Lindefors N, Hurd YL, O'Connor WT, Brené S, Persson H, Ungerstedt U. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience. 48: 439-48. PMID 1603328 DOI: 10.1016/0306-4522(92)90503-T  1
1992 Lindefors N, Ernfors P, Falkenberg T, Persson H. Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus. Experimental Brain Research. 88: 78-90. PMID 1541364 DOI: 10.1007/BF02259130  1
1992 Kopp J, Lindefors N, Brené S, Hall H, Persson H, Sedvall G. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain. Neuroscience. 47: 771-9. PMID 1533704 DOI: 10.1016/0306-4522(92)90028-Z  1
1992 Falkenberg T, Ernfors P, Persson H, Lindefors N. Cortical transynaptic activation of tyrosine kinase receptor trkB messenger RNA expression in rat hippocampus. Neuroscience. 51: 883-9. PMID 1488128 DOI: 10.1016/0306-4522(92)90527-9  1
1992 Brené S, Lindefors N, Ballarin M, Persson H. Kainic acid-mediated increase of preprotachykinin-A messenger RNA expression in the rat hippocampus and a region-selective attenuation by dexamethasone. Neuroscience. 50: 611-8. PMID 1436505 DOI: 10.1016/0306-4522(92)90450-G  1
1992 Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neuroscience Letters. 138: 153-6. PMID 1407655 DOI: 10.1016/0304-3940(92)90494-R  1
1992 Sedvall CG, Farde L, Hall H, Halldin C, Karlsson P, Brene S, Lindefors N, Persson H, Chipkin RE, Ehrlich M. Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain. Clinical Neuropharmacology. 15: 466A-467A. PMID 1386781  1
1992 Hurd YL, Lindefors N, Brodin E, Brené S, Persson H, Ungerstedt U, Hökfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Research. 578: 317-26. PMID 1354999 DOI: 10.1016/0006-8993(92)90264-A  1
1992 Brené S, Lindefors N, Persson H. Midbrain dopamine neurons regulate preprotachykinin-A mRNA expression in the rat forebrain during development. Brain Research. Molecular Brain Research. 14: 13-9. PMID 1323010 DOI: 10.1016/0169-328X(92)90004-U  1
1992 Lindefors N, Ballarin M, Ernfors P, Falkenberg T, Persson H. Stimulation of glutamate receptors increases expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Annals of the New York Academy of Sciences. 648: 296-9. PMID 1322082  1
1992 Lindefors N. Amphetamine and haloperidol modulate preprotachykinin A mRNA expression in rat nucleus accumbens and caudate-putamen. Brain Research. Molecular Brain Research. 13: 151-4. PMID 1315912 DOI: 10.1016/0169-328X(92)90055-G  1
1991 Lindefors N, Brené S, Kopp J, Lindén A, Brodin E, Sedvall G, Persson H. Distribution of cholecystokinin mRNA and peptides in the human brain. Neuroscience. 42: 813-21. PMID 1956517 DOI: 10.1016/0306-4522(91)90046-Q  1
1991 O'Connor WT, Lindefors N, Brené S, Herrera-Marschitz M, Persson H, Ungerstedt U. Short-term dopaminergic regulation of GABA release in dopamine deafferented caudate-putamen is not directly associated with glutamic acid decarboxylase gene expression. Neuroscience Letters. 128: 66-70. PMID 1922949 DOI: 10.1016/0304-3940(91)90761-H  1
1991 Ballarín M, Ernfors P, Lindefors N, Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Experimental Neurology. 114: 35-43. PMID 1915733 DOI: 10.1016/0014-4886(91)90082-N  1
1991 Lindefors N, Brodin K, Stiller CO, Persson H, Brodin E. Repeated electroconvulsive shock increases tachykinin and cholecystokinin mRNA expression in ventral periaqueductal gray. Neuroscience. 45: 73-80. PMID 1754069 DOI: 10.1016/0306-4522(91)90104-V  1
1990 Lindefors N, Brené S, Herrera-Marschitz M, Persson H. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons. Experimental Brain Research. 80: 489-500. PMID 2387350 DOI: 10.1007/BF00227990  1
1990 Lindefors N, Brené S, Persson H. Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen. Brain Research. Molecular Brain Research. 7: 207-12. PMID 2159580 DOI: 10.1016/0169-328X(90)90029-D  1
1990 Brené S, Lindefors N, Herrera-Marschitz M, Persson H. Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen. Experimental Brain Research. 83: 96-104. PMID 2150048 DOI: 10.1007/BF00232197  1
1990 Brené S, Lindefors N, Friedman WJ, Persson H. Preprotachykinin A mRNA expression in the rat brain during development. Brain Research. Developmental Brain Research. 57: 151-62. PMID 1981494 DOI: 10.1016/0165-3806(90)90041-V  1
1990 Lindefors N, Brené S, Herrera-Marschitz M, Persson H. Regulation of neuropeptide Y gene expression in rat brain. Annals of the New York Academy of Sciences. 611: 175-85. PMID 1978997  1
1990 Lindefors N, Ungerstedt U. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neuroscience Letters. 115: 248-52. PMID 1978265 DOI: 10.1016/0304-3940(90)90463-J  1
1990 Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Experimental Brain Research. 82: 293-303. PMID 1704847 DOI: 10.1007/BF00231249  1
1990 Ernfors P, Lindefors N, Chan-Palay V, Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the alzheimer type Dementia and Geriatric Cognitive Disorders. 1: 138-145. DOI: 10.1159/000107133  1
1989 Brené S, Lindefors N, Kopp J, Sedvall G, Persson H. Regional distribution of neuropeptide Y mRNA in postmortem human brain. Brain Research. Molecular Brain Research. 6: 241-9. PMID 2593779 DOI: 10.1016/0169-328X(89)90070-3  1
1989 Amberg G, Lindefors N. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. Journal of Pharmacological Methods. 22: 157-83. PMID 2586112 DOI: 10.1016/0160-5402(89)90012-0  1
1989 Lindefors N, Amberg G, Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. Journal of Pharmacological Methods. 22: 141-56. PMID 2586111 DOI: 10.1016/0160-5402(89)90011-9  1
1989 Lindefors N, Brene S, Herrera-Marschitz M, Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Experimental Brain Research. 77: 611-20. PMID 2572447 DOI: 10.1007/BF00249614  1
1989 Lindefors N, Brodin E, Ungerstedt U. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. European Journal of Pharmacology. 160: 417-20. PMID 2540996 DOI: 10.1016/0014-2999(89)90100-3  1
1989 Lindefors N, Brodin E, Ungerstedt U. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra. European Journal of Pharmacology. 161: 95-8. PMID 2470596 DOI: 10.1016/0014-2999(89)90185-4  1
1989 Lindefors N, Brodin E, Tossman U, Segovia J, Ungerstedt U. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Experimental Brain Research. 74: 527-34. PMID 2468514 DOI: 10.1007/BF00247354  1
1987 Lindefors N, Tossman U, Ungerstedt U. Subchronic haloperidol and sulpiride treatment induces region-specific changes in tissue levels of putative amino acid transmitters in rat brain. Neuroscience Letters. 74: 90-4. PMID 2882448 DOI: 10.1016/0304-3940(87)90057-7  1
1987 Lindefors N, Brodin E, Ungerstedt U. Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides. Journal of Pharmacological Methods. 17: 305-12. PMID 2441208 DOI: 10.1016/0160-5402(87)90044-1  1
1986 Lindefors N, Sharp T, Ungerstedt U. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat. European Journal of Pharmacology. 129: 401-4. PMID 3780852 DOI: 10.1016/0014-2999(86)90457-7  1
1986 Lindefors N, Brodin E, Ungerstedt U. Neurokinin A and substance P in striato-nigral neurons in rat brain. Neuropeptides. 8: 127-32. PMID 2429229 DOI: 10.1016/0143-4179(86)90039-9  1
1986 Lindefors N, Yamamoto Y, Pantaleo T, Lagercrantz H, Brodin E, Ungerstedt U. In vivo release of substance P in the nucleus tractus solitarii increases during hypoxia. Neuroscience Letters. 69: 94-7. PMID 2427979 DOI: 10.1016/0304-3940(86)90421-0  1
1986 Lindefors N, Brodin E, Ungerstedt U. Neuroleptic treatment induces region-specific changes in levels of neurokinin A and substance P in rat brain. Neuropeptides. 7: 265-80. PMID 2423911 DOI: 10.1016/0143-4179(86)90021-1  1
1986 Brodin E, Lindefors N, Dalsgaard CJ, Theodorsson-Norheim E, Rosell S. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regulatory Peptides. 13: 253-72. PMID 2422706 DOI: 10.1016/0167-0115(86)90044-3  1
1985 Lindefors N, Brodin E, Theodorsson-Norheim E, Ungerstedt U. Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro. Neuropeptides. 6: 453-61. PMID 2997657 DOI: 10.1016/0143-4179(85)90144-1  1
1985 Lindefors N, Brodin E, Theodorsson-Norheim E, Ungerstedt U. Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins. Regulatory Peptides. 10: 217-30. PMID 2581287 DOI: 10.1016/0167-0115(85)90016-3  1
1985 Brodin E, Lindefors N, Theodorsson-Norheim E. Tachykinins in rat central nervous system: Distribution, molecular forms, release and effects of chronic treatment with antidepressant drugs Fernstrom Foundation Series. 15-27.  1
1983 Brodin E, Lindefors N, Ungerstedt U. Potassium evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassay. Acta Physiologica Scandinavica. Supplementum. 515: 17-20. PMID 6194653  1
Show low-probability matches.